Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 2

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 2
---
 for the Class A Ordinary Shares will be determined at the time of pricing.

For purposes of this prospectus,
we have assumed an offering price of $ per Class A Ordinary Shares, which is the Company’s last reported closing price of our
Class A Ordinary Shares on August , 2025, solely to provide the necessary disclosures that require a calculation based on the offering
price. The actual public offering price may be lower than the assumed price and may be at a discount to the current market price. Accordingly,
the assumed offering price used throughout this prospectus is not indicative of the final public offering price.

Our authorized and issued
ordinary shares are divided into Class A Ordinary Shares and Class B Ordinary Shares. The number of Class A Ordinary Shares and Class
B Ordinary Shares currently issued and outstanding was 2,152,702 as of August 20, 2025. Each Class A Ordinary Share is entitled to one
(1) vote and each Class B Ordinary Share is entitled to one hundred (100) votes. Class B Ordinary Share is convertible into
one Class A Ordinary Share at any time by the holder thereof, while Class A Ordinary Shares are not convertible into Class B Ordinary
Shares under any circumstances.

Because there is no minimum offering amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the event that we do not sell a number of securities sufficient to pursue the business goals outlined in this prospectus. Because there is no minimum offering amount, investors could be in a position where they have invested in our company, but we are unable to fulfill our objectives due to a lack of interest in this offering. Any proceeds from the sale of Class A Ordinary Shares and Warrants offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. See “Use of Proceeds” on page 64 for more information.

Upon completion of this offering,
our issued and outstanding shares will consist of Class A Ordinary Shares and Class B Ordinary Shares.

Further issuances of Class
B Ordinary Shares may be dilutive to holders of our Class A Ordinary Shares. It could have the effect of increasing the overall voting
power of Class B Shareholders relative to Class A Shareholders, diluting, and diminishing the influence and control of Class A
Shareholders over our company’s affairs.

Our Class A Ordinary Shares